iRGD peptide 1 TFA
iRGD peptide 1 TFA, a paramount biomedical innovation, embodies incredible potential in cancer therapeutics. This exquisitely engineered peptide elucidates extraordinary proficiency in tumor targeting, revolutionizing drug transportation to malignant cells. Its profound impact on drug infiltration into tumor microenvironment burgeons therapeutic efficacy, effectively augmenting the potency of anticancer agents. With unparalleled benefits, iRGD peptide 1 TFA emerges as a groundbreaking solution towards combating cancer.
Online Inquiry
| CAT# | GR2188 |
| M.F/Formula | C37H60F3N13O16S2 |
| M.W/Mr. | 1064.08 |
| Appearance | Solid |
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Write a review
Ask a question
My Review for iRGD peptide 1 TFA
Required fields are marked with *
×
Ask a Question for iRGD peptide 1 TFA
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
